Hepatitis B virus therapy with nucleos(t)ide analogues significantly reduces fibrosis in a 'Real-world' Canadian cohort

被引：0
|
作者：
Ramji, A. [1 ]
Coffin, C. [2 ]
Ko, H. H. [1 ]
Wong, A. [3 ]
Shaheen, A. A. [4 ]
Cooper, C. [5 ]
机构：
[1] Univ British Columbia, Gastroenterol, Vancouver, BC, Canada
[2] Univ Calgary, Gastroenterol & Hepatol, Calgary, AB, Canada
[3] Univ Saskatchewan, Infect Dis, Regina, SK, Canada
[4] Univ Calgary, Gastroenterol, Calgary, AB, Canada
[5] Univ Ottawa, Infect Dis, Ottawa, ON, Canada
来源：
JOURNAL OF VIRAL HEPATITIS | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1-044
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [21] Real-world experience with nucleos(t)ide analogue therapy and patient survival rates in chronic viral hepatitis B treatment centers in Eritrea
    Solomon, Michael Berhe
    Ghebremeskel, Ghirmay Ghebrekidan
    Achila, Oliver Okoth
    Mebrahtu, Aron Rezene
    Hamida, Mohammed Elfatih
    Mesfin, Araia Berhane
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [22] Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
    Irene Rapti
    Stephanos Hadziyannis
    World Journal of Hepatology, 2015, 7 (08) : 1064 - 1073
  • [23] Hepatitis B: when is discontinuation of treatment with nucleos(t)ide analogues justified?
    van Boemmel, F.
    Berg, T.
    GASTROENTEROLOGE, 2021, 16 (06): : 417 - 432
  • [24] Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
    Lee, I-Cheng
    Sun, Cheuk-Kay
    Su, Chien-Wei
    Wang, Yuan-Jen
    Chang, Hung-Chuen
    Huang, Hui-Chun
    Lee, Kuei-Chuan
    Huang, Yi-Shin
    Perng, Chin-Lin
    Liu, Yuh-Hwa
    Chua, Chian-Sem
    Lin, Yu-Min
    Lin, Han-Chieh
    Huang, Yi-Hsiang
    MEDICINE, 2015, 94 (32)
  • [25] Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues
    Leung, Nancy
    HEPATOLOGY INTERNATIONAL, 2008, 2 (02) : 163 - 178
  • [26] Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues
    Buster, Erik H. C. J.
    Schalm, Solko W.
    Janssen, Harry L. A.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2008, 22 (06) : 1093 - 1108
  • [27] Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy
    Liu, Shi
    Deng, Rui
    Zhou, Bin
    Liang, Xieer
    Liu, Zhihong
    Peng, Jie
    Chen, Jinjun
    Zhou, Yuanping
    Guo, Yabing
    Chen, Yongpeng
    Li, Wanying
    Shen, Sheng
    Lu, Xingyu
    Zhao, Siru
    Liao, Xingmei
    Liang, Hongyan
    Lan, Yu
    Hou, Jinlin
    Fan, Rong
    Sun, Jian
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (05): : 881 - 890
  • [28] Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?
    Kao, Jia--Horng
    Berg, Thomas
    GUT, 2019, 68 (12) : 2105 - 2106
  • [29] Predictors of Nucleos(t)ide Analogues Discontinuation Relapse: Hepatitis B Virus RNA versus Hepatitis B Surface Antigen
    Wu, Shuo
    Li, Tao
    Liu, Feng
    Yin, Dedong
    Zhang, Lixin
    Wang, Lei
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (05): : 545 - 550
  • [30] Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
    Rapti, Irene
    Hadziyannis, Stephanos
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (08) : 1064 - 1073
12345